• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13D filed by ModivCare Inc.

    11/8/24 9:59:28 PM ET
    $MODV
    Transportation Services
    Consumer Discretionary
    Get the next $MODV alert in real time by email
    SC 13D 1 ef20038317_sc13d.htm SC 13D
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
     
    SCHEDULE 13D
     
    Under the Securities Exchange Act of 1934
     
    MODIVCARE INC.

    (Name of Issuer)

    Common Stock, $0.001 par value

    (Title of Class of Securities)

    60783X104

    (CUSIP Number)

    Nelson Holm
    301 Commerce Street, Suite 3200
    Fort Worth, Texas 76102
    (817) 332-9500

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
     
    November 7, 2024

    (Date of Event which Requires Filing of this Statement)

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box ☒.
     
    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).



    SCHEDULE 13D
     
    CUSIP No.
    60783X104

    1
    NAMES OF REPORTING PERSONS
     
     
    Q GLOBAL CAPITAL MANAGEMENT, L.P.
    26-4357778
     
     
     
     
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a)
    ☐

    (b)
    ☐
     
     
    3
    SEC USE ONLY
     
     

     
     
     
     
    4
    SOURCE OF FUNDS (SEE INSTRUCTIONS)
     
     
    OO (1)
     
     
     
     
    5
    CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
     
    ☐

     
     
     
     
    6
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
     
    Texas
     
     
     
     
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    7
    SOLE VOTING POWER
     
     
    1,812,725 (2)
     
     
     
     
    8
    SHARED VOTING POWER
     
     
    0
     
     
     
     
    9
    SOLE DISPOSITIVE POWER
     
     
    1,812,725 (2)
     
     
     
     
    10
    SHARED DISPOSITIVE POWER
     
     
    0
     
     
     
     
    11
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
     
    1,812,725 (2)
     
     
     
     
    12
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
     
    ☐

     
     
     
     
    13
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
     
     
    12.69% (2) (3)
     
     
     
     
    14
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
     
     
    PN
     
     
     
     


    (1)
    See Item 3.
     

    (2)
    Q Global Capital Management, L.P., has sole voting and dispositive power over the shares reported herein as the investment manager of Q5-R5 Trading, Ltd.
     

    (3)
    Calculated based on 14,283,664 shares of the Common Stock, par value $0.001 per share, of ModivCare, Inc. outstanding as of November 1, 2024, as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 7, 2024.

    2 of 8

    Item 1.
    Security and Issuer
     
    This Schedule 13D relates to the shares of the Common Stock, par value $0.001 per share (the “Common Stock”), of ModivCare, Inc., a Delaware corporation (the “Issuer”), whose principal executive offices are located at 6900 Layton Avenue, 12th Floor, Denver, Colorado, 80237.
     
    Item 2.
    Identity and Background
     
    (a) Pursuant to Regulation 13D-G of the General Rules and Regulations under the Securities Exchange Act of 1934, as amended (the “Act”), the undersigned hereby files this Schedule 13D Statement on behalf of Q Global Capital Management, L.P. (“QGCM”), a Texas limited partnership (the “Reporting Person”) that is the investment manager of Q5-R5 Trading, Ltd., a Cayman limited company (“Q5”).  Additionally, information is included herein with respect to the following persons (collectively, the “Controlling Persons”): Q Global Advisors, LLC, a Texas limited liability company (“QGA”), Renegade Swish, LLC, a Delaware limited liability company (“RS”), and Geoffrey Raynor (“Raynor”). The Reporting Person and the Controlling Persons are sometimes hereinafter collectively referred to as the “Item 2 Persons.” The Item 2 Persons are making this single, joint filing because they may be deemed to constitute a “group” within the meaning of Section 13(d)(3) of the Act, although neither the fact of this filing nor anything contained herein shall be deemed to be an admission by the Item 2 Persons that such a group exists.
     
    (b)-(c), (f)
     
    Reporting Person
     
    The principal business of QGCM is serving as the investment manager of Q5 and activities related thereto.  The principal address of QGCM, which also serves as its principal office, is 301 Commerce Street, Suite 3200, Fort Worth, Texas 76102.
     
    Controlling Persons
     
    The principal address of each Controlling Person, which also serves as the principal office of each Controlling Person, is 301 Commerce Street, Suite 3200, Fort Worth, Texas 76102.  The principal business of RS, a Delaware limited liability company, is serving as the manager of QGA and other entities and activities related thereto.  Raynor, a citizen of the United States of America, controls and indirectly wholly owns RS.
     
    Raynor’s principal occupation or employment is serving as the President of RS and activities related thereto.
     
    (d) None of the Item 2 Persons has, during the last five years, been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).
     
    (e) None of the Item 2 Persons has, during the last five years, been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

    3 of 8

    Item 3.
    Source and Amount of Funds or Other Considerations
     
    QGCM has not expended any of its funds for purchases of the Common Stock reported herein.  QGCM, however, expended $33,023,403.58 (excluding commissions and fees) of the funds of Q5 to purchase the shares of the Common Stock reported herein (the “Shares”).
     
    Item 4.
    Purpose of Transaction
     
    Between August 16, 2023, and November 7, 2024, the Reporting Person acquired beneficial ownership of the Shares for investment purposes in the ordinary course of business in the belief that the Common Stock is undervalued and represents an attractive investment opportunity.  The Reporting Person is currently supportive of the Issuer’s CEO in general. However, the Reporting Person believes that the Issuer’s performance, both recently and over the last ten years, has been disappointing.  The Issuer released its quarterly earnings on November 6, 2024 and, on November 7, 2024, held the related earnings call and subsequent conference call between the Reporting Person and the Issuer (collectively, the “November 7 Earnings Call”).  Following the November 7 Earnings Call, the Reporting Person decided that because the strategic actions that were previously communicated by the Issuer as under consideration and/or discussed in analyst reports covering the Issuer had not been completed --- for example, the Issuer did not announce a covenant relief amendment to the Issuer’s revolving credit facility despite announcing on October 1, 2024 that such an amendment was “anticipated to be finalized in the near term”, and the Earnings Call gave the indication the Issuer is delaying any potential monetization of the Issuer’s minority interest in CCHN Group Holdings, Inc. (“CCHN”), which operates under the Matrix Medical Network Brand, and is not considering raising debt financing secured by the Issuer’s interest in CCHN --- the Reporting Person should consider more options, as enumerated by the list (a) through (h) below. The Reporting Person continues to evaluate the Issuer, its prospects and the decisions of its board of directors and management team, as well as the Reporting Person’s holding of the Shares, on a continuing basis.
     
    Consistent with its obligations under the federal securities laws and other limitations, and depending on various factors including the Issuer’s financial position, the price levels of the Shares, the Issuer’s results and strategic direction, actions taken by the Issuer’s management and its board of directors, conditions in the healthcare services industry and securities markets, general economic and industry conditions, other investment opportunities available to the Reporting Person, and other factors the Reporting Person may deem relevant to its investment decision, the Reporting Person will in the future take such actions with respect to its investment in the Issuer as it deems appropriate. Such actions may include, without limitation: (a) holding its investment in the Issuer; (b) increasing or decreasing its position in the Issuer through, among other things, the purchase or sale of the Common Stock in open market or private transactions for cash or for other consideration; (c) seeking to influence control of the Issuer, the means of which may include seeking to obtain representation on, or to otherwise influence the composition of, the Issuer’s board; (d) advocating for a process to explore the sale of the Issuer’s minority interest in CCHN, or for raising debt financing secured by the Issuer’s interest in CCHN; (e) advocating for other deleveraging transactions; (f) advocating for executing a covenant relief amendment to the Issuer’s revolving credit facility in a timely manner; (g) engaging with other shareholders regarding their views; and (h) taking other actions similar to those listed above.  The Reporting Person expects to engage in discussions with third parties as it evaluates its investment and considers whether to take any of the foregoing actions; however, the Issuer cannot predict, among other things, whether it will take any of the foregoing actions and, if so, the timing thereof.
     
    Except as set forth above, the Reporting Person has no present plans or proposals that relate to or would result in any of the matters referred to in paragraphs (a) through (j), inclusive, of Item 4 of Schedule 13D. However, the Reporting Person retains its right to modify its plans with respect to the transactions described in this Item 4, to acquire or dispose of Shares and to formulate plans and proposals that could result in the occurrence of any such events, subject to applicable laws and regulations.
     
    Item 5.
    Interest in Securities of the Issuer
     
    (a)
     
    Reporting Person
     
    QGCM

    Because of its position as the sole investment manager of Q5, QGCM may, pursuant to Rule 13d-3(d)(1)(i) of the Act, be deemed to be the beneficial owner of 1,812,725 shares of Common Stock, which constitutes approximately 12.69% of the 14,283,664 shares of the Common Stock outstanding as of November 1, 2024, as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 7, 2024.

    4 of 8

    Controlling Persons
     
    QGA
     
    Because of its position as the sole general partner of QGCM, QGA may, pursuant to Rule 13d-3(d)(1)(i) of the Act, be deemed to be the beneficial owner of 1,812,725 shares of Common Stock, which constitutes approximately 12.69% of the 14,283,664 shares of the Common Stock outstanding as of November 1, 2024, as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 7, 2024.
     
    RS
     
    Because of its position as the sole manager of QGA, RS may, pursuant to Rule 13d-3(d)(1)(i) of the Act, be deemed to be the beneficial owner of 1,812,725 shares of Common Stock, which constitutes approximately 12.69% of the 14,283,664 shares of the Common Stock outstanding as of November 1, 2024, as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 7, 2024.
     
    Raynor
     
    Since Raynor controls and indirectly wholly owns RS, which is the sole manager of QGA, Raynor may, pursuant to Rule 13d-3(d)(1)(i) of the Act, be deemed to be the beneficial owner of 1,812,725 shares of Common Stock, which constitutes approximately 12.69% of the 14,283,664 shares of the Common Stock outstanding as of November 1, 2024, as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 7, 2024.
     
    To the best of the knowledge of the Reporting Person, other than as set forth above, none of the persons named in Item 2 herein is the beneficial owner of any shares of the Common Stock.
     
    (b)
     
    Reporting Person
     
    QGCM
     
    As the sole as the sole investment manager of Q5, QGCM has the sole power to vote or to direct the vote and to dispose or direct the disposition of 1,812,725 shares of the Common Stock.
     
    Controlling Persons
     
    QGA
     
    As the sole general partner of QGCM, QGA has the sole power to vote or to direct the vote and to dispose or direct the disposition of 1,812,725 shares of the Common Stock.
     
    RS

    As the sole manager of QGA, RS has the sole power to vote or to direct the vote and to dispose or direct the disposition of 1,812,725 shares of the Common Stock.
     

    5 of 8

    Raynor
     
    Since Raynor controls and indirectly wholly owns RS, which is the sole manager of QGA, Raynor has the sole power to vote or to direct the vote and to dispose or direct the disposition of 1,812,725 shares of the Common Stock.
     
     (c)
     
    During the past 60 days, the Reporting Person purchased or sold shares of Common Stock in open market as follows:

    Date
    Number of Shares
    Transaction Type
    Price Per Share in ($) (1)
    Fill Prices in ($) (2)
    11/7/2024
    24,624
    Purchase
    16.54
    16.06 to 16.75
    11/7/2024
    33,567
    Purchase
    17.57
    17.25 to 17.75
    11/5/2024
    11,990
    Purchase
    16.22
    16.085 to 16.25
    11/4/2024
    20,927
    Purchase
    16.13
    16.00 to 16.25
    11/1/2024
    33,495
    Purchase
    16.15
    15.915 to 16.25
    10/31/2024
    67,728
    Purchase
    15.99
    15.73 to 16.25
    10/30/2024
    38,292
    Purchase
    15.89
    15.47 to 16.12
    10/29/2024
    36,212
    Purchase
    15.56
    15.101 to 16.00
    10/28/2024
    25,496
    Purchase
    15.69
    15.457 to 16.00
    10/25/2024
    20,556
    Purchase
    14.65
    14.39 to 14.94

     
    6 of 8



    10/24/2024
    24,800
    Purchase
    14.36
    14.067 to 14.50
    10/23/2024
    52,927
    Purchase
    14.15
    13.845 to 14.50
    10/22/2024
    17,000
    Purchase
    14.61
    14.4 to 14.75
    10/21/2024
    54,674
    Purchase
    14.85
    14.45 to 15.20
    10/18/2024
    3,100
    Sale
    15.87
    15.82 to 15.90
    10/18/2024
    108,534
    Purchase
    16.01
    15.795 to 16.25
    10/17/2024
    55,150
    Purchase
    16.27
    15.95 to 16.75
    10/17/2024
    11,197
    Purchase
    17.12
    16.7599 to 17.25
    10/16/2024
    48,832
    Purchase
    17.04
    16.735 to 17.25
    10/15/2024
    24,374
    Purchase
    16.97
    16.55 to 17.00
    10/14/2024
    8,696
    Purchase
    16.59
    16.41 to 16.66
    10/11/2024
    14,343
    Purchase
    16.55
    15.91 to 16.66
    10/10/2024
    17,735
    Purchase
    15.96
    15.68 to 16.24
    10/9/2024
    30,666
    Purchase
    16.13
    15.85 to 16.3585
    10/7/2024
    12,028
    Purchase
    16.11
    15.4642 to 16.39
    10/7/2024
    3,225
    Purchase
    16.65
    16.44 to 16.94
    10/4/2024
    11,833
    Purchase
    16.95
    16.864 to 17.00
    10/1/2024
    4,824
    Purchase
    14.21
    14.1156 to 14.25
    9/30/2024
    323
    Purchase
    13.95
    13.87 to 13.99
    9/30/2024
    58,742
    Purchase
    14.66
    14.205 to 15.00
    9/30/2024
    -500
    Sale
    14.9
    14.90 to 14.90
    9/27/2024
    21,579
    Purchase
    12.83
    12.08 to 13.02
    9/27/2024
    47,677
    Purchase
    13.77
    13.025 to 14.00
    9/27/2024
    54,714
    Purchase
    14.08
    14.0033 to 14.25
    9/27/2024
    -1,500
    Sale
    12.23
    12.20 to 12.29
    9/27/2024
    -300
    Sale
    13.56
    13.40 to 13.83
    9/26/2024
    21,332
    Purchase
    12.16
    12.01 to 12.25
    9/25/2024
    6,927
    Purchase
    11.61
    NO FILL DATA
    9/24/2024
    30,307
    Purchase
    12.13
    12.00 to 12.28
    9/24/2024
    -5,000
    Sale
    12.13
    12.10 to 12.20
    9/23/2024
    127,048
    Purchase
    12.09
    11.90 to 12.47
    9/23/2024
    -5,000
    Sale
    11.96
    11.95 to 12.00
    9/11/2024
    1,522
    Purchase
    29.95
    29.73 to 30.00
    9/10/2024
    4,229
    Purchase
    29.99
    29.87 to 30.00
    9/9/2024
    2,264
    Sale
    32.25
    32.00 to 32.495
     
    (1) The price reported in the “Price Per Share” column above excludes commission and fees.
     
    (2) The price reported in the “Price Per Share” column above reflects the weighted average purchase price. The transaction was executed in multiple trades in prices in the range set forth in this column. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each respective price within the ranges set forth in this column.
    7 of 8

    (d)
     
    The Reporting Person affirms that no person other than the persons named in Item 2 has the right to receive, or the power to direct the receipt of dividends from, or proceeds from the sale of, the shares of the Common Stock owned by such Reporting Person.
     
    (e)
     
    Not applicable.
     
    Item 6.
    Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer
     
    Q5 also holds $33,110,000 of the principal amount of the Issuer’s Senior Notes due in 2029.
     
    Texas Exchange Bank, a Texas state bank, which may be considered an affiliate of the Reporting Person, holds $34,095,000 of the principal amount of the Issuer’s term loan facility.
     
    Item 7.
    Material to Be Filed as Exhibits
     
    Not applicable.
     
    Signature
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
     
       
    Dated
     
    Q GLOBAL CAPITAL MANAGEMENT, L.P.

    By: Q Global Advisors, LLC, its general partner

    /s/ Nelson Holm
     
    By: Nelson Holm, Assistant Secretary
     
     

    8 of 8

    Get the next $MODV alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MODV

    DatePrice TargetRatingAnalyst
    8/9/2024$35.00Mkt Perform → Outperform
    Barrington Research
    5/6/2024$50.00Hold → Buy
    Lake Street
    2/23/2024$60.00 → $40.00Buy → Hold
    Deutsche Bank
    2/23/2024$60.00 → $39.00Buy → Hold
    Jefferies
    8/3/2022$145.00Overweight
    Stephens
    2/28/2022$190.00 → $155.00Outperform
    Barrington Research
    2/3/2022$180.00 → $150.00Buy
    Deutsche Bank
    12/17/2021$180.00Buy
    Deutsche Bank
    More analyst ratings

    $MODV
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Modivcare Reports First Quarter 2025 Financial Results

      Modivcare Inc. (the "Company" or "Modivcare") (NASDAQ:MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, today reported financial results for the three months ended March 31, 2025. "In Q1, we continued to advance our strategic objectives and operational initiatives," said L. Heath Sampson, President and CEO. "Company-wide alignment on key initiatives—securing new contracts, laying the groundwork for scalable automation, reducing G&A, strengthening our working-capital discipline, and progressing toward divestiture readiness—positions us to deliver enhanced performance and long-term va

      5/8/25 4:53:00 PM ET
      $MODV
      Transportation Services
      Consumer Discretionary
    • Modivcare Announces Executive Leadership Transitions as Part of Strategic Business Model Evolution

      Modivcare Inc. (NASDAQ:MODV), a technology-enabled healthcare services company that provides supportive care solutions to address the social determinants of health, today announced the planned departures of two members of its executive leadership team as the company continues to align its structure with its evolving business model and modernization strategy. Barb Gutierrez, Chief Financial Officer, and Jessica Kral, Chief Information Officer, will be departing the company following a period of transition. Barb's and Jessica's departures come as Modivcare evolves its organizational structure in an effort to support the next phase of its modernization strategy—built on the financial and tech

      5/5/25 6:30:00 AM ET
      $MODV
      Transportation Services
      Consumer Discretionary
    • Modivcare to Report First Quarter 2025 Financial Results

      Modivcare Inc. ("Modivcare" or the "Company") (NASDAQ:MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, today announced that the Company is scheduled to report financial results for the first quarter ended March 31, 2025, on Thursday, May 8, 2025, after the market closes and host a conference call at 5:00 p.m. Eastern Time the same day. The conference call dial-in number for domestic callers is (877) 407-8037, and international callers should dial +1 (201) 689-8037. Interested parties may also access the live webcast via the Company's website at: https://investors.modivcare.com/even

      4/28/25 4:05:00 PM ET
      $MODV
      Transportation Services
      Consumer Discretionary

    $MODV
    Financials

    Live finance-specific insights

    See more
    • Modivcare Reports First Quarter 2025 Financial Results

      Modivcare Inc. (the "Company" or "Modivcare") (NASDAQ:MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, today reported financial results for the three months ended March 31, 2025. "In Q1, we continued to advance our strategic objectives and operational initiatives," said L. Heath Sampson, President and CEO. "Company-wide alignment on key initiatives—securing new contracts, laying the groundwork for scalable automation, reducing G&A, strengthening our working-capital discipline, and progressing toward divestiture readiness—positions us to deliver enhanced performance and long-term va

      5/8/25 4:53:00 PM ET
      $MODV
      Transportation Services
      Consumer Discretionary
    • Modivcare to Report First Quarter 2025 Financial Results

      Modivcare Inc. ("Modivcare" or the "Company") (NASDAQ:MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, today announced that the Company is scheduled to report financial results for the first quarter ended March 31, 2025, on Thursday, May 8, 2025, after the market closes and host a conference call at 5:00 p.m. Eastern Time the same day. The conference call dial-in number for domestic callers is (877) 407-8037, and international callers should dial +1 (201) 689-8037. Interested parties may also access the live webcast via the Company's website at: https://investors.modivcare.com/even

      4/28/25 4:05:00 PM ET
      $MODV
      Transportation Services
      Consumer Discretionary
    • Modivcare Reports Fourth Quarter and Full Year 2024 Financial Results; Announces Changes to the Board of Directors

      Modivcare Inc. (the "Company" or "Modivcare") (NASDAQ:MODV), a technology-enabled healthcare services company that provides a suite of integrated supportive care solutions focused on improving patient outcomes, today reported financial results for the three months and full year ended December 31, 2024. Fourth Quarter 2024 Summary: Service revenue of $702.8 million, remaining consistent with the fourth quarter of 2023 Net loss of $23.5 million, or negative $1.64 per diluted common share Adjusted EBITDA(1) of $40.4 million, adjusted net income(1) of $2.7 million and adjusted EPS(1) of $0.19 per diluted common share Net cash provided by operating activities during the quarter of $30.0

      3/6/25 4:23:00 PM ET
      $MODV
      Transportation Services
      Consumer Discretionary

    $MODV
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • ModivCare upgraded by Barrington Research with a new price target

      Barrington Research upgraded ModivCare from Mkt Perform to Outperform and set a new price target of $35.00

      8/9/24 9:17:22 AM ET
      $MODV
      Transportation Services
      Consumer Discretionary
    • ModivCare upgraded by Lake Street with a new price target

      Lake Street upgraded ModivCare from Hold to Buy and set a new price target of $50.00

      5/6/24 8:28:24 AM ET
      $MODV
      Transportation Services
      Consumer Discretionary
    • ModivCare downgraded by Deutsche Bank with a new price target

      Deutsche Bank downgraded ModivCare from Buy to Hold and set a new price target of $40.00 from $60.00 previously

      2/23/24 7:11:03 AM ET
      $MODV
      Transportation Services
      Consumer Discretionary

    $MODV
    SEC Filings

    See more
    • ModivCare Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits

      8-K - ModivCare Inc (0001220754) (Filer)

      5/8/25 4:52:15 PM ET
      $MODV
      Transportation Services
      Consumer Discretionary
    • SEC Form 8-K filed by ModivCare Inc.

      8-K - ModivCare Inc (0001220754) (Filer)

      5/5/25 6:34:16 AM ET
      $MODV
      Transportation Services
      Consumer Discretionary
    • SEC Form DEFA14A filed by ModivCare Inc.

      DEFA14A - ModivCare Inc (0001220754) (Filer)

      4/30/25 4:57:23 PM ET
      $MODV
      Transportation Services
      Consumer Discretionary

    $MODV
    Leadership Updates

    Live Leadership Updates

    See more

    $MODV
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Modivcare Announces Changes to Board of Directors

      Seasoned Executive Daniel Silvers Brings Decades of Experience in Corporate Finance, Capital Allocation and Public Company Governance Modivcare Inc. ("Modivcare" or the "Company") (NASDAQ:MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, today announced that Daniel Silvers has been appointed to its board of directors (the "Board"), effective April 24, 2025. The appointment of Mr. Silvers completes the Board's previously announced plan to add three new independent directors pursuant to its contractual obligations with its lenders. "We welcome Mr. Silvers to the Board and are confide

      4/25/25 6:30:00 AM ET
      $MODV
      Transportation Services
      Consumer Discretionary
    • Modivcare Announces Changes to Board of Directors

      Financial and Healthcare Executive Erin L. Russell Brings Decades of Experience in Healthcare Capital Markets and Strategy Modivcare Inc. (the "Company" or "Modivcare") (NASDAQ:MODV), a technology-enabled healthcare services company providing a platform of integrated supportive care solutions focused on improving health outcomes, today announced that Erin L. Russell has been appointed to its board of directors (the "Board"), effective February 10, 2025. Ms. Russell brings more than 25 years of experience in the healthcare and financial sectors, with a distinguished track record in capital and credit markets. On the Board, Ms. Russell will be a member of the Audit and Nominating and Govern

      2/14/25 6:00:00 AM ET
      $EHTH
      $KAI
      $MODV
      $TVTY
      Specialty Insurers
      Finance
      Industrial Machinery/Components
      Industrials
    • GE Vernova and Solventum Set to Join S&P 500; Dentsply Sirona to Join S&P MidCap 400; Others to Join S&P SmallCap 600

      NEW YORK, March 27, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400 and S&P SmallCap 600: Solventum Corp. (NYSE:SOLV) will be added to the S&P 500 effective prior to the open of trading on Monday, April 1, replacing V.F. Corp. (NYSE:VFC), which will be moved to the S&P SmallCap 600 effective prior to the open of trading on Wednesday, April 3. V.F. will replace ModivCare Inc. (NASD: MODV) in the S&P SmallCap 600 also effective prior to the open of trading on April 3. S&P 500 and 100 constituent 3M Co. (NYSE:MMM) is spinning off Solventum in a transaction expected to be completed April 1. Following the spin-off, the parent 3M will rema

      3/27/24 6:12:00 PM ET
      $FOXF
      $GE
      $MMM
      $MODV
      Motor Vehicles
      Consumer Discretionary
      Consumer Electronics/Appliances
      Technology
    • Amendment: SEC Form SC 13D/A filed by ModivCare Inc.

      SC 13D/A - ModivCare Inc (0001220754) (Subject)

      12/13/24 9:05:42 PM ET
      $MODV
      Transportation Services
      Consumer Discretionary
    • Amendment: SEC Form SC 13D/A filed by ModivCare Inc.

      SC 13D/A - ModivCare Inc (0001220754) (Subject)

      12/13/24 5:07:48 PM ET
      $MODV
      Transportation Services
      Consumer Discretionary
    • Amendment: SEC Form SC 13D/A filed by ModivCare Inc.

      SC 13D/A - ModivCare Inc (0001220754) (Subject)

      12/9/24 7:46:13 PM ET
      $MODV
      Transportation Services
      Consumer Discretionary

    $MODV
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 3 filed by new insider Silvers Daniel B.

      3 - ModivCare Inc (0001220754) (Issuer)

      4/28/25 7:00:13 AM ET
      $MODV
      Transportation Services
      Consumer Discretionary
    • New insider Mounts Gonzales David claimed ownership of 2,130,000 shares (SEC Form 3)

      3 - ModivCare Inc (0001220754) (Issuer)

      3/17/25 4:46:20 PM ET
      $MODV
      Transportation Services
      Consumer Discretionary
    • SEC Form 3 filed by new insider Cunningham Alexander R.

      3 - ModivCare Inc (0001220754) (Issuer)

      3/17/25 4:33:30 PM ET
      $MODV
      Transportation Services
      Consumer Discretionary

    $MODV
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Large owner Ai Catalyst Fund, Lp bought $1,677,000 worth of shares (420,000 units at $3.99) (SEC Form 4)

      4 - ModivCare Inc (0001220754) (Issuer)

      2/3/25 9:56:40 PM ET
      $MODV
      Transportation Services
      Consumer Discretionary
    • Large owner Coliseum Capital Management, Llc bought $9,995,856 worth of shares (1,502,424 units at $6.65) (SEC Form 4)

      4 - ModivCare Inc (0001220754) (Issuer)

      1/14/25 7:32:58 PM ET
      $MODV
      Transportation Services
      Consumer Discretionary
    • Large owner Q Global Capital Management, L.P. bought $48,385 worth of shares (3,837 units at $12.61) and sold $5,400,260 worth of shares (749,002 units at $7.21) (SEC Form 4)

      4 - ModivCare Inc (0001220754) (Issuer)

      1/13/25 6:35:04 PM ET
      $MODV
      Transportation Services
      Consumer Discretionary